These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3603420)

  • 1. Antithrombotic activity of a synthetic heparin pentasaccharide in a rabbit stasis thrombosis model using different thrombogenic challenges.
    Walenga JM; Petitou M; Lormeau JC; Samama M; Fareed J; Choay J
    Thromb Res; 1987 Apr; 46(2):187-98. PubMed ID: 3603420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous antithrombotic activity of a synthetic heparin pentasaccharide in a human serum induced stasis thrombosis model.
    Walenga JM; Fareed J; Petitou M; Samama M; Lormeau JC; Choay J
    Thromb Res; 1986 Jul; 43(2):243-8. PubMed ID: 3738864
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the antithrombotic effects and pharmacokinetics of heparin fractions and fragments.
    Fareed J; Walenga JM; Williamson K; Emanuele RM; Kumar A; Hoppensteadt DA
    Semin Thromb Hemost; 1985 Jan; 11(1):56-74. PubMed ID: 3883500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and antithrombotic properties of two pentasaccharides with high affinity to antithrombin III in the rabbit: comparison with CY216.
    Carrie D; Caranobe C; Saivin S; Houin G; Petitou M; Lormeau JC; Van Boeckel C; Meuleman D; Boneu B
    Blood; 1994 Oct; 84(8):2571-7. PubMed ID: 7919374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of a 3-O-sulfate group in a heparin pentasaccharide for antithrombotic activity.
    Walenga JM; Petitou M; Samama M; Fareed J; Choay J
    Thromb Res; 1988 Dec; 52(6):553-63. PubMed ID: 3232125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
    Thomas DP; Merton RE; Barrowcliffe TW; Thunberg L; Lindahl U
    Thromb Haemost; 1982 Jun; 47(3):244-8. PubMed ID: 7112499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity.
    Walenga JM; Bara L; Petitou M; Samama M; Fareed J; Choay J
    Thromb Res; 1988 Jul; 51(1):23-33. PubMed ID: 3166242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharide.
    Herbert JM; Hérault JP; Bernat A; van Amsterdam RG; Lormeau JC; Petitou M; van Boeckel C; Hoffmann P; Meuleman DG
    Blood; 1998 Jun; 91(11):4197-205. PubMed ID: 9596667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of antithrombotic activity of two heparin fragments PK 10169 (mol. wt. 5,000) and EMT 680 (mol. wt. 2,500) and unfractionated heparin in a rabbit experimental thrombosis model: relative importance of systemic anti-Xa and anti-IIa activities.
    Bara L; Trillou M; Mardiguian J; Samama M
    Nouv Rev Fr Hematol (1978); 1986; 28(6):355-8. PubMed ID: 3562219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic effects of heparin oligosaccharides.
    Mattsson C; Palm M; Söderberg K; Holmer E
    Ann N Y Acad Sci; 1989; 556():323-32. PubMed ID: 2735663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic potencies of heparins in relation to their antifactor Xa and antithrombin activities: an experimental study in two models of thrombosis in the rabbit.
    Amar J; Caranobe C; Sie P; Boneu B
    Br J Haematol; 1990 Sep; 76(1):94-100. PubMed ID: 2223652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentasaccharide and Orgaran arrest, whereas heparin delays thrombus formation in a rat arteriovenous shunt.
    Vogel GM; van Amsterdam RG; Kop WJ; Meuleman DG
    Thromb Haemost; 1993 Jan; 69(1):29-34. PubMed ID: 8446935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relative antithrombotic effectiveness of heparin, a low molecular weight heparin, and a pentasaccharide fragment in an animal model.
    Thomas DP; Merton RE; Gray E; Barrowcliffe TW
    Thromb Haemost; 1989 Apr; 61(2):204-7. PubMed ID: 2546282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifactor Xa activity and antithrombotic activity in rats of structural analogues of the minimum antithrombin III binding sequence: discovery of compounds with a longer duration of action than of the natural pentasaccharide.
    Meuleman DG; Hobbelen PM; Van Dinther TG; Vogel GM; Van Boeckel CA; Moelker HC
    Semin Thromb Hemost; 1991; 17 Suppl 1():112-7. PubMed ID: 2068564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
    Thomas DP; Merton RE; Barrowcliffe TW
    Ann N Y Acad Sci; 1989; 556():313-22. PubMed ID: 2735662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin.
    Herbert JM; Hérault JP; Bernat A; van Amsterdam RG; Vogel GM; Lormeau JC; Petitou M; Meuleman DG
    Circ Res; 1996 Sep; 79(3):590-600. PubMed ID: 8781492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified stasis thrombosis model to study the antithrombotic actions of heparin and its fractions.
    Fareed J; Walenga JM; Kumar A; Rock A
    Semin Thromb Hemost; 1985 Apr; 11(2):155-75. PubMed ID: 3929386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance between the anti-Xa activity and the antithrombotic activity in an ultra-low molecular weight heparin fraction.
    Ockelford PA; Carter CJ; Mitchell L; Hirsh J
    Thromb Res; 1982 Nov; 28(3):401-9. PubMed ID: 7179224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does not.
    Cadroy Y; Dol F; Caranobe C; Petitou M; Lormeau JC; Sié P; Choay J; Boneu B
    Thromb Haemost; 1988 Apr; 59(2):295-8. PubMed ID: 2838927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.